Regulatory Issues
- events/archive March 14, 2007 Thinking Big About Things Small New Report Looks Beyond Specific Statutes at Effective Oversight System video
- publications/archive March 1, 2007 Thinking Big About Things Small: Creating an Effective Oversight System for Nanotechnology
- publications/archive March 1, 2007 Nanotechnology and Life Cycle Assessment: A Systems Approach to Nanotechnology and the Environment
- publications/archive November 16, 2006 Safe Handling of Nanotechnology
- publications/archive October 10, 2006 FDA and Nanotechnology: Public Perceptions Matter
- publications/archive October 10, 2006 Statement of Michael R. Taylor at FDA hearing
- news/archive October 10, 2006 Nanotech Knocks on FDA’s Door “Thanks to the promise of nanotechnology, people will benefit from fantastic new prescription drugs and from better ways of getting existing pharmaceuticals into the body for more effective disease treatments. But new nano-enabled drugs and medical devices also place new burdens on an oversight agency that is already stretched extremely thin,” said Project on Emerging Nanotechnologies Director David Rejeski in a presentation today at the Food and Drug Administration’s first major public meeting on regulating products containing nanotechnology materials. video
- news/archive October 6, 2006 Project Comments Submitted to FDA in Advance of Public Hearing
- publications/archive October 5, 2006 FDA-Regulated Products Containing Nanotechnology Materials
- events/archive October 5, 2006 Regulating the Products of Nanotechnology Former Food and Drug Administration (FDA) Deputy Commissioner for Policy Michael R. Taylor analyzes FDA’s ability to properly protect the American public from the potential hazards associated with nanotechnology in a new report, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? video
- news/archive October 5, 2006 Is FDA Nanotech-Ready? A new report released today, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? by Michael Taylor, a former Deputy Commissioner for Policy at the Food and Drug Administration (FDA), examines the agency’s capacity to properly regulate new products containing nanotechnology materials—including food, drugs, medical devices, dietary supplements and cosmetics. video audio
- publications/archive October 1, 2006 Regulating the Products of Nanotechnology: Does FDA Have the Tools it Needs?
- publications/archive September 21, 2006 Testimony in front of the U.S. House of Representatives Committee on Science
- publications/archive July 19, 2006 FDA-Regulated products containing nanotechnology materials
- publications/archive July 1, 2006 Falling Through the Cracks? Public Perception, Risk, and the Oversight of Emerging Nanotechnologies
